543 related articles for article (PubMed ID: 28818473)
1. Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study.
Kondo K; Suzuki K; Washio M; Ohfuji S; Fukushima W; Maeda A; Hirota Y;
Vaccine; 2017 Aug; 35(36):4806-4810. PubMed ID: 28818473
[TBL] [Abstract][Full Text] [Related]
2. Preventive effects of pneumococcal and influenza vaccines on community-acquired pneumonia in older individuals in Japan: a case-control study.
Suzuki K; Kondo K; Washio M; Nakashima K; Kan S; Imai S; Yoshimura K; Ota C; Ohfuji S; Fukushima W; Hirota Y
Hum Vaccin Immunother; 2019; 15(9):2171-2177. PubMed ID: 30785356
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.
Domínguez A; Castilla J; Godoy P; Delgado-Rodríguez M; Saez M; Soldevila N; Astray J; Mayoral JM; Martín V; Quintana JM; González-Candelas F; Galán JC; Tamames S; Castro A; Baricot M; Garín O; Pumarola T;
Hum Vaccin Immunother; 2013 Apr; 9(4):865-73. PubMed ID: 23563516
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of a 23-valent pneumococcal polysaccharide vaccine for the prevention of pneumococcal pneumonia in the elderly with chronic respiratory diseases: a case-control study of a single center.
Masuda T; Nakatani E; Shirai T; Akamatsu T; Tamura K; Takahashi S; Tanaka Y; Watanabe H; Endo Y; Suzuki T; Saigusa M; Yamamoto A; Morita S; Sato Y; Asada K
BMC Pulm Med; 2021 Apr; 21(1):123. PubMed ID: 33863300
[TBL] [Abstract][Full Text] [Related]
5. [Effect of influenza and 23-valent pneumococcal polysaccharide vaccinations on elderly with chronic obstructive pulmonary diseases: a community-based intervention study].
Wen Y; He L; Zhai Y; Wu J; Chen YY; Wang H; Zong QQ; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):792-798. PubMed ID: 29936749
[No Abstract] [Full Text] [Related]
6. Effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive disease and hospital-treated pneumonia among people aged ≥65 years: a retrospective case-control study.
Leventer-Roberts M; Feldman BS; Brufman I; Cohen-Stavi CJ; Hoshen M; Balicer RD
Clin Infect Dis; 2015 May; 60(10):1472-80. PubMed ID: 25669354
[TBL] [Abstract][Full Text] [Related]
7. The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.
Tsai YH; Hsieh MJ; Chang CJ; Wen YW; Hu HC; Chao YN; Huang YC; Yang CT; Huang CC
Vaccine; 2015 Jun; 33(25):2897-902. PubMed ID: 25936662
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in older individuals after the introduction of childhood 13-valent pneumococcal conjugate vaccine: A multicenter hospital-based case-control study in Japan.
Nakashima K; Suzuki K; Aoshima M; Murabata M; Kondo K; Ohfuji S; Fukushima W; Maeda A; Hirota Y;
Vaccine; 2022 Nov; 40(46):6589-6598. PubMed ID: 36184405
[TBL] [Abstract][Full Text] [Related]
9. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in patients with chronic pulmonary diseases: a matched case-control study.
Vila-Corcoles A; Ochoa-Gondar O; Rodriguez-Blanco T; Gutierrez-Perez A; Vila-Rovira A;
Hum Vaccin Immunother; 2012 May; 8(5):639-44. PubMed ID: 22634442
[TBL] [Abstract][Full Text] [Related]
10. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study.
Vila-Corcoles A; Salsench E; Rodriguez-Blanco T; Ochoa-Gondar O; de Diego C; Valdivieso A; Hospital I; Gomez-Bertomeu F; Raga X
Vaccine; 2009 Mar; 27(10):1504-10. PubMed ID: 19171174
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly.
Domínguez A; Izquierdo C; Salleras L; Ruiz L; Sousa D; Bayas JM; Nebot M; Varona W; Celorrio JM; Carratalà J;
Eur Respir J; 2010 Sep; 36(3):608-14. PubMed ID: 20075048
[TBL] [Abstract][Full Text] [Related]
12. Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysis.
Zhang YY; Tang XF; Du CH; Wang BB; Bi ZW; Dong BR
Hum Vaccin Immunother; 2016 Dec; 12(12):3056-3064. PubMed ID: 27629584
[TBL] [Abstract][Full Text] [Related]
13. Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization.
Song JY; Lee JS; Wie SH; Kim HY; Lee J; Seo YB; Jeong HW; Kim SW; Lee SH; Park KH; Noh JY; Choi WS; Cheong HJ; Kim WJ
Clin Vaccine Immunol; 2015 Feb; 22(2):229-34. PubMed ID: 25540271
[TBL] [Abstract][Full Text] [Related]
14. [Vaccination against community acquired pneumonia in adult patients. A position paper by Neumoexpertos en Prevención].
Redondo E; Rivero I; Vargas DA; Mascarós E; Díaz-Maroto JL; Linares M; Valdepérez J; Gil A; Molina J; Jimeno I; Ocaña D; Martinón-Torres F;
Semergen; 2016 Oct; 42(7):464-475. PubMed ID: 27641310
[TBL] [Abstract][Full Text] [Related]
15. Association between monovalent influenza A (H1N1) pdm09 vaccine and pneumonia among the elderly in the 2009-2010 season in Japan: A case-control study.
Kondo K; Suzuki K; Washio M; Ohfuji S; Fukushima W; Maeda A; Hirota Y;
Hum Vaccin Immunother; 2015; 11(5):1088-93. PubMed ID: 25901995
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of 23-valent pneumococcal polysaccharide vaccine on elderly long-term cancer survivors: a population-based propensity score matched cohort study.
Chiou WY; Lee MS; Hung SK; Lin HY; Lo YC; Hsu FC; Tsai SJ; Li CY
BMJ Open; 2018 May; 8(5):e019364. PubMed ID: 29769253
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.
Vila-Córcoles A; Ochoa-Gondar O; Hospital I; Ansa X; Vilanova A; Rodríguez T; Llor C;
Clin Infect Dis; 2006 Oct; 43(7):860-8. PubMed ID: 16941367
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
Baldo V; Cocchio S; Gallo T; Furlan P; Romor P; Bertoncello C; Buja A; Baldovin T
PLoS One; 2016; 11(11):e0166637. PubMed ID: 27846277
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan.
Kawakami K; Ohkusa Y; Kuroki R; Tanaka T; Koyama K; Harada Y; Iwanaga K; Yamaryo T; Oishi K
Vaccine; 2010 Oct; 28(43):7063-9. PubMed ID: 20723631
[TBL] [Abstract][Full Text] [Related]
20. Effect of 23-Valent Pneumococcal Polysaccharide Vaccine Inoculated During Anti-Cancer Treatment Period in Elderly Lung Cancer Patients on Community-Acquired Pneumonia Hospitalization: A Nationwide Population-Based Cohort Study.
Chiou WY; Hung SK; Lai CL; Lin HY; Su YC; Chen YC; Shen BJ; Chen LC; Tsai SJ; Lee MS; Li CY
Medicine (Baltimore); 2015 Jul; 94(26):e1022. PubMed ID: 26131806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
